Prothena Beheer
Beheer criteriumcontroles 2/4
De CEO Prothena is Gene Kinney, benoemd in Sep2016, heeft een ambtstermijn van 8.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 7.04M, bestaande uit 9% salaris en 91% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.024% van de aandelen van het bedrijf, ter waarde $ 213.03K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.7 jaar en 5.1 jaar.
Belangrijke informatie
Gene Kinney
Algemeen directeur
US$7.0m
Totale compensatie
| Percentage CEO-salaris | 9.0% |
| Dienstverband CEO | 8.2yrs |
| Eigendom CEO | 0.02% |
| Management gemiddelde ambtstermijn | 7.7yrs |
| Gemiddelde ambtstermijn bestuur | 5.1yrs |
Recente managementupdates
Recent updates
Prothena: Delays And Data Uncertainty Undermine Case For Investing (Downgrade)
Oct 18Prothena Corporation plc (NASDAQ:PRTA) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough
Oct 02
Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares
Jul 26Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Jun 19Prothena: Potential For Future Price Drop On Failure Risk Of Late-Stage Trials
Jun 07New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)
May 14Prothena: Alzheimer's Data Update In 2024 Could Move The Needle
Feb 23Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%
Feb 08Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?
Dec 20Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business
Nov 24Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk
Oct 27Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Aug 25What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today
May 10We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth
Apr 23Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook
Mar 01We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate
Dec 28Prothena: Paying A Premium To Cover All The Alzheimer's Bases
Sep 29Prothena GAAP EPS of -$0.88 misses by $0.31
Aug 08Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates
May 08Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$51m |
| Mar 31 2024 | n/a | n/a | -US$172m |
| Dec 31 2023 | US$7m | US$631k | -US$147m |
| Sep 30 2023 | n/a | n/a | -US$73m |
| Jun 30 2023 | n/a | n/a | -US$141m |
| Mar 31 2023 | n/a | n/a | -US$128m |
| Dec 31 2022 | US$7m | US$601k | -US$117m |
| Sep 30 2022 | n/a | n/a | -US$156m |
| Jun 30 2022 | n/a | n/a | -US$1m |
| Mar 31 2022 | n/a | n/a | US$67m |
| Dec 31 2021 | US$5m | US$573k | US$67m |
| Sep 30 2021 | n/a | n/a | US$69m |
| Jun 30 2021 | n/a | n/a | -US$70m |
| Mar 31 2021 | n/a | n/a | -US$124m |
| Dec 31 2020 | US$3m | US$554k | -US$111m |
| Sep 30 2020 | n/a | n/a | -US$102m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$80m |
| Dec 31 2019 | US$3m | US$538k | -US$78m |
| Sep 30 2019 | n/a | n/a | -US$79m |
| Jun 30 2019 | n/a | n/a | -US$84m |
| Mar 31 2019 | n/a | n/a | -US$128m |
| Dec 31 2018 | US$11m | US$525k | -US$156m |
| Sep 30 2018 | n/a | n/a | -US$181m |
| Jun 30 2018 | n/a | n/a | -US$209m |
| Mar 31 2018 | n/a | n/a | -US$167m |
| Dec 31 2017 | US$5m | US$521k | -US$153m |
Compensatie versus markt: De totale vergoeding ($USD 7.04M ) Gene } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.23M ).
Compensatie versus inkomsten: De vergoeding van Gene is gestegen terwijl het bedrijf verliesgevend is.
CEO
Gene Kinney (55 yo)
8.2yrs
Tenure
US$7,043,826
Compensatie
Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 8.2yrs | US$7.04m | 0.024% $ 213.0k | |
| CFO & Chief Strategy Officer | 11.7yrs | US$2.70m | 0.0060% $ 53.3k | |
| Chief Operating Officer | 3.1yrs | US$2.63m | 0% $ 0 | |
| Chief Regulatory Officer | 7.9yrs | US$2.57m | 0% $ 0 | |
| Chief Accounting Officer & Controller | 11.5yrs | geen gegevens | geen gegevens | |
| Chief Scientific Officer | 7.4yrs | US$3.34m | geen gegevens | |
| Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
| Chief Legal Officer | no data | US$1.18m | geen gegevens | |
| Chief People Officer | less than a year | geen gegevens | geen gegevens | |
| Chief Development Officer | less than a year | geen gegevens | geen gegevens | |
| Company Secretary | no data | geen gegevens | geen gegevens |
7.7yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van PRTA is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 8.2yrs | US$7.04m | 0.024% $ 213.0k | |
| Independent Director | 2.3yrs | US$896.63k | 0% $ 0 | |
| Independent Director | 11.9yrs | US$912.48k | 0.0023% $ 20.3k | |
| Independent Chairman | less than a year | geen gegevens | geen gegevens | |
| Independent Chair Emeritus | less than a year | US$923.48k | 0.00045% $ 4.0k | |
| Independent Director | 11.9yrs | US$917.26k | 0% $ 0 | |
| Independent Director | 11.3yrs | US$901.73k | 0.0078% $ 70.0k | |
| Independent Director | 5.3yrs | US$908.48k | 0% $ 0 | |
| Independent Director | 4.9yrs | geen gegevens | geen gegevens | |
| Independent Director | 1.5yrs | US$1.70m | geen gegevens |
5.1yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van PRTA wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.1 jaar).